2003
DOI: 10.1074/jbc.m305594200
|View full text |Cite
|
Sign up to set email alerts
|

TR3 Orphan Nuclear Receptor Mediates Apoptosis through Up-regulating E2F1 in Human Prostate Cancer LNCaP Cells

Abstract: Early studies suggested both TR3 orphan receptor (TR3) and apoptosis mediator E2F1 might play an important role in mediating prostate cancer cell apoptosis. Their linkage and relationship, however, remain unclear. Here we found that 12-O-tetradecanoylphorbol-13-acetate (TPA) could induce cell apoptosis via induction of TR3 and E2F1 expression in LNCaP prostate cancer cells. Addition of antisense E2F1 could partially rescue the TR3-mediated cell apoptosis, and transfection of the TR3 dominant-negative plasmid c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
45
1

Year Published

2007
2007
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(47 citation statements)
references
References 38 publications
(56 reference statements)
1
45
1
Order By: Relevance
“…40 Involvement of TR3 in chemotherapeutic agent induced apoptosis is common, [41][42][43] such as in ATRA-induced MCF-7 breast cancer cell apoptosis, 24 AHPN/CD437-induced lung and prostate cancer cell apoptosis, 41 and butyrate induced apoptosis in HCT116 colon cancer cells. 33 In contrast to other tumors, we showed that ATRA and cisplatin did not upregulate TR3 expression, but rather partially altered its subcellular distribution, and induced melanoma cell apoptosis.…”
Section: Tr3 Mediates Melanoma Cell Apoptosismentioning
confidence: 99%
“…40 Involvement of TR3 in chemotherapeutic agent induced apoptosis is common, [41][42][43] such as in ATRA-induced MCF-7 breast cancer cell apoptosis, 24 AHPN/CD437-induced lung and prostate cancer cell apoptosis, 41 and butyrate induced apoptosis in HCT116 colon cancer cells. 33 In contrast to other tumors, we showed that ATRA and cisplatin did not upregulate TR3 expression, but rather partially altered its subcellular distribution, and induced melanoma cell apoptosis.…”
Section: Tr3 Mediates Melanoma Cell Apoptosismentioning
confidence: 99%
“…Moreover, when endogenous Pin1 was knocked down via Pin1-siRNA, TR3 can no longer influence cyclin D2 expression (Figure 4d, right). In addition, Pin1 also influenced the association of TR3 with the promoter of E2F1 (Supplementary Figure S4E), another target gene of TR3 (Mu and Chang, 2003), accompanying with the upregulation of E2F1 expression (Figure 4d; Supplementary Figure S4F). Together, these results consistently indicate that the prolyl cis/trans isomerization catalyzed by Pin1 is a prerequisite for TR3 to stimulate the expression of its downstream target genes.…”
Section: Pin1 Stabilizes Tr3 Protein By Blocking Its Degradationmentioning
confidence: 96%
“…Although the studies cited above indicate that NR4A1 contributes to carcinogenesis, many others report the opposite effect of NR4A1 on tumor growth (Mohan et al, 2012). NR4A1 expression is modified to inhibit tumor formation in many tumor types, including colon, breast, bladder, liver, thyroid, lung, prostate, and renal cell carcinoma (Choi et al, 2004;Mohan et al, 2012;Mu and Chang, 2003). As noted earlier, NR4A1 promotes apoptosis in a human prostate cancer cell line through stimulation of E2F1 expression (Mu and Chang, 2003).…”
Section: Cancer and Clinical Translationmentioning
confidence: 97%
“…NR4A1 expression is modified to inhibit tumor formation in many tumor types, including colon, breast, bladder, liver, thyroid, lung, prostate, and renal cell carcinoma (Choi et al, 2004;Mohan et al, 2012;Mu and Chang, 2003). As noted earlier, NR4A1 promotes apoptosis in a human prostate cancer cell line through stimulation of E2F1 expression (Mu and Chang, 2003). Early induction of NR4A1 in a human breast cancer cell line causes A23187-induced cell death via the CREB signaling pathway (Ohkubo et al, 2000).…”
Section: Cancer and Clinical Translationmentioning
confidence: 99%
See 1 more Smart Citation